Investing
CapEx
Edwards Lifesciences CapEx decreased by 33.4% to $64.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 15.9%, from $56.00M to $64.90M. Over 4 years (FY 2021 to FY 2025), CapEx shows a downward trend with a -5.5% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2013
Last reportedQ1 2026
How to read this metric
An increase signals growth investment or infrastructure modernization; a decrease might suggest cost-cutting or a transition to an asset-light model.
Detailed definition
Funds used by a company to acquire, upgrade, and maintain physical assets such as property, plants, buildings, technolog...
Peer comparison
Hardware-focused tech firms typically have higher CapEx relative to revenue than pure software companies due to manufacturing and supply chain needs.
Metric ID:
capital_expendituresHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $69.30M | $60.70M | $89.80M | $72.70M | $43.10M | $59.90M | $68.90M | $61.50M | $47.90M | $55.30M | $88.30M | $65.30M | $85.40M | $51.90M | $49.80M | $56.00M | $49.30M | $57.50M | $97.40M | $64.90M |
| QoQ Change | — | -12.4% | +47.9% | -19.0% | -40.7% | +39.0% | +15.0% | -10.7% | -22.1% | +15.4% | +59.7% | -26.0% | +30.8% | -39.2% | -4.0% | +12.4% | -12.0% | +16.6% | +69.4% | -33.4% |
| YoY Change | — | — | — | — | -37.8% | -1.3% | -23.3% | -15.4% | +11.1% | -7.7% | +28.2% | +6.2% | +78.3% | -6.1% | -43.6% | -14.2% | -42.3% | +10.8% | +95.6% | +15.9% |
Range$43.10M – $97.40M
CAGR-1.4%
Avg YoY Growth+3.4%
Median YoY Growth-3.7%
CapEx at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's capex?
- Edwards Lifesciences (EW) reported capex of $64.90M in Q1 2026.
- How has Edwards Lifesciences's capex changed year-over-year?
- Edwards Lifesciences's capex increased by 15.9% year-over-year, from $56.00M to $64.90M.
- What is the long-term trend for Edwards Lifesciences's capex?
- Over 4 years (2021 to 2025), Edwards Lifesciences's capex has grown at a -5.5% compound annual growth rate (CAGR), from $325.80M to $260.20M.
- What does capex mean?
- The money spent on long-term physical assets like machinery, data centers, and office buildings.